MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jnci/dju129

Медицинская библиотека · Journal of the National Cancer Institute · 2014

Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Reeve Bryce B, Mitchell Sandra A, Dueck Amylou C, Basch Ethan, Cella David, Reilly Carolyn Miller, Minasian Lori M, Denicoff Andrea M, O'Mara Ann M, Fisch Michael J, Chauhan Cynthia, Aaronson Neil K, Coens Corneel, Bruner Deborah Watkins

Consensus Development Conference, NIHСтатьяСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

The National Cancer Institute's Symptom Management and Health-Related Quality of Life Steering Committee held a clinical trials planning meeting (September 2011) to identify a core symptom set to be assessed across oncology trials for the purposes of better understanding treatment efficacy and toxicity and to facilitate cross-study comparisons. We report the results of an evidence-synthesis and consensus-building effort that culminated in recommendations for core symptoms to be measured in adult cancer clinical trials that include a patient-reported outcome (PRO).

METHODS

We used a data-driven, consensus-building process. A panel of experts, including patient representatives, conducted a systematic review of the literature (2001-2011) and analyzed six large datasets. Results were reviewed at a multistakeholder meeting, and a final set was derived emphasizing symptom prevalence across diverse cancer populations, impact on health outcomes and quality of life, and attribution to either disease or anticancer treatment.

RESULTS

We recommend that a core set of 12 symptoms--specifically fatigue, insomnia, pain, anorexia (appetite loss), dyspnea, cognitive problems, anxiety (includes worry), nausea, depression (includes sadness), sensory neuropathy, constipation, and diarrhea--be considered for inclusion in clinical trials where a PRO is measured. Inclusion of symptoms and other patient-reported endpoints should be well justified, hypothesis driven, and meaningful to patients.

CONCLUSIONS

This core set will promote consistent assessment of common and clinically relevant disease- and treatment-related symptoms across cancer trials. As such, it provides a foundation to support data harmonization and continued efforts to enhance measurement of patient-centered outcomes in cancer clinical trials and observational studies.

Для цитирования: Reeve Bryce B, Mitchell Sandra A, Dueck Amylou C, Basch Ethan, Cella David, Reilly Carolyn Miller, Minasian Lori M, Denicoff Andrea M, O'Mara Ann M, Fisch Michael J, Chauhan Cynthia, Aaronson Neil K, Coens Corneel, Bruner Deborah Watkins. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.. Journal of the National Cancer Institute. 2014. DOI: 10.1093/jnci/dju129.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.